Solara Active Pharma Sciences Limited (NSE:SOLARA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Active Pharmaceutical Ingredient	12.83B	12.89B	14.44B	12.68B	16.17B
Active Pharmaceutical Ingredient Growth	-0.46%	-10.73%	13.83%	-21.56%	22.33%
Total	12.83B	12.89B	14.44B	12.68B	16.17B
Total Growth	-0.46%	-10.73%	13.83%	-21.56%	22.33%

Source: S&P Global Market Intelligence.